NAD+ 500mg Research Coenzyme
NAD+ — USA Made, ≥99% Purity
4.9 177 verified reviews- 500mg oxidized NAD+ research material supplied as lyophilized powder
- USA manufactured in GMP-certified California and Arizona laboratory facilities
- ≥99% purity target with third-party HPLC, mass spectrometry, and combined batch COA
For research purposes only. Not intended for human consumption, medical use, diagnosis, treatment, or prevention of disease.
Specifications
Lot NA430- CAS
- 53-84-9
- Molecular mass
- 663.43 g/mol (anhydrous free-acid basis)
- Purity target
- ≥99% (3rd-Party HPLC Tested)
- Form
- Lyophilized Powder
- Origin
- Manufactured, Formulated & Packaged in CA/AZ, USA
- Storage
- Store at -20°C (Freeze) or 2–8°C (Refrigerated) protected from light
What is NAD+?
NAD+—nicotinamide adenine dinucleotide—is an oxidized coenzyme found throughout cellular metabolism. It is not a peptide; it is a two-nucleotide molecule that helps enzymes transfer electrons and run essential biochemical reactions.
Researchers use NAD+ to study redox balance, energy metabolism, enzyme activity, and cellular signaling. It also serves as a consumed substrate for enzyme families including sirtuins, PARPs, and CD38, making its availability relevant to many different experimental systems.
How It Works
Carries electrons: NAD+ accepts reducing equivalents to form NADH during metabolic redox reactions.
Connects metabolic pathways: The NAD+/NADH pair supports reactions linked to glycolysis, the TCA cycle, and oxidative metabolism.
Feeds signaling enzymes: Sirtuins, PARPs, and other NAD+-consuming enzymes use the molecule during protein regulation and DNA-response processes.
Every lot, on the record
Independent third-party HPLC evaluates the purity target, while mass spectrometry confirms molecular identity. Both results are documented in one combined, batch-specific Certificate of Analysis.
- Identity (LC-MS)
- Confirmed
- Appearance
- White Lyophilized Powder
| Analyte | Method | Specification | Result | Pass/fail |
|---|---|---|---|---|
| Identity | LC-MS | NAD+ | ||
| Purity | HPLC-UV | 99.83% | ||
| Net Content | 535.51 mg |
Chromatogram
Mass confirmation
Why Source from 321 Peptides?
Lot history 4 released lots
Every batch released under this compound, with the figure reported for each.
| Lot | Reported | Purity | Net content | COA |
|---|---|---|---|---|
| NA430 | 2026-06-01 | 99.83% | 535.51 mg | |
| NA-75688 Superseded | 2026-05-12 | 99.64% | 502.00 mg | Pending |
| NA-76265 Superseded | 2026-04-30 | 99.88% | 502.50 mg | Pending |
| NA-76842 Superseded | 2026-02-25 | 99.71% | 503.00 mg | Pending |